Sangamo BioSciences, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 24,133 21,655 10,319 20,805
Cost of Revenue - - - -
Gross Profit 24,133 21,655 10,319 20,805
Operating Expenses
Research and Development 36,979 31,709 32,098 33,154
Sales, General and Admin. 13,860 12,144 14,042 12,586
Non-Recurring Items - - - -
Other - - - -
Operating Income (26,706) (22,198) (35,821) (24,935)
Income From Continuing Operations
Add'l Income/Expense Items 82 (66) 71 81
Earnings Before Interest and Tax (26,624) (22,264) (35,750) (24,854)
Interest Expense - - - -
Earnings Before Tax (26,624) (22,264) (35,750) (24,854)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (26,624) (22,264) (35,750) (24,854)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (26,624) (22,264) (35,750) (24,854)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (26,624) (22,264) (35,750) (24,854)